Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason E Long

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
<i>Kras</i> mutant genetically engineered mouse models of human cancers are genomically heterogeneousWei-Jen Chung, Anneleen Daemen, Jason H Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Tumor Elastography and Its Association with Collagen and the Tumor MicroenvironmentJohannes Riegler, Yassin Labyed, Stephen Rosenzweig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
Cell Death and Differentiation|March 3, 2019
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptationJason E Long, Matthew J Wongchenko, Dorothee Nickles, et al.
The Journal of Comparative Neurology|December 2, 2009
Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neuronsRaquel Martín-Ibáñez, Empar Crespo, Noelia Urbán, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
<i>Kras</i> mutant genetically engineered mouse models of human cancers are genomically heterogeneousWei-Jen Chung, Anneleen Daemen, Jason H Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Tumor Elastography and Its Association with Collagen and the Tumor MicroenvironmentJohannes Riegler, Yassin Labyed, Stephen Rosenzweig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
Cell Death and Differentiation|March 3, 2019
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptationJason E Long, Matthew J Wongchenko, Dorothee Nickles, et al.
The Journal of Comparative Neurology|December 2, 2009
Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neuronsRaquel Martín-Ibáñez, Empar Crespo, Noelia Urbán, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
The Journal of Pathology|May 22, 2012
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour modelsMallika Singh, Suzana S Couto, William F Forrest, et al.
Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.
Pageof 3